TP53 and plasma cell myeloma: In addition, shRNA-mediated DEPCD1 knockdown in human myeloma cell lines was shown to significantly inhibit cell proliferation and induce accumulation in G2/M in TP53 wild-type cells and marked apoptosis in TP53 mutant cells [29].